Inhibikase Therapeutics IKT
NASDAQ IKT
$1.55 -0.12 (-7.19%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibikase Therapeutics (IKT) Times Interest Earned (2020 - 2023)

Updated

Inhibikase Therapeutics' (IKT) Times Interest Earned came in at -928119.20 for Q1 2022, compared with -222.54 a year earlier.

Analysis

Inhibikase Therapeutics (IKT) Times Interest Earned (2020 - 2023) Analysis & Trends

For FY2021, Inhibikase Therapeutics' Times Interest Earned stood at -741.16.

  • In prior years, Inhibikase Therapeutics' Times Interest Earned was -95.86 in FY2020.
  • The Q1 2022 figure stands as the lowest quarterly Times Interest Earned in data going back to Q1 2020.
  • According to Business Quant data, Times Interest Earned for the three prior quarters was -31907.98 (Q4 2021), -28477.96 (Q3 2021) and -336.50 (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 28.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.20
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 5.68
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.87
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Inhibikase Therapeutics 281.11 Mn -420.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -27.46
Jun 30, 2023 0.00
Mar 31, 2022 -928,119.20
Dec 31, 2021 -31,907.98
Sep 30, 2021 -28,477.96
Jun 30, 2021 -336.50
Mar 31, 2021 -222.54
Dec 31, 2020 -168.21
Sep 30, 2020 -96.33
Jun 30, 2020 -52.08
Mar 31, 2020 -72.73
API Access

Inhibikase Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=IKT&period=max&api_key=YOUR_API_KEY